Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-02-03 @ 11:13 AM
Study NCT ID:
NCT01955460
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2013-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2013-09-27
First Submit QC Date:
None
Study First Post Date:
2013-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED